1. Discuss the evidence for definitive local treatment of oligometastatic disease in NSCLC.
2. Discuss the evidence for control of intra-cranial metastatic disease with immunotherapy or systemic therapy.
10/25/2018 - 8:00am to 9:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Sherin J. Rouhani, M.D.